Table 3.
Multivariate analysis using the Cox proportional hazards model.
| Variables | HR (95% CI) | P-value |
|---|---|---|
| OS | ||
| TNM Stage III, IV | 3.49 (0.98–12.44) | 0.054 |
| Lymph node metastasis | 0.87 (0.21–3.59) | 0.843 |
| CEA > 5, μg/L | 1.42 (0.67–3.01) | 0.355 |
| AZGP1 | 0.45 (0.21–0.96) | 0.038 |
| Tumor differentiation | 2.06 (1.06–4.01) | 0.033 |
| Diabetes | 1.72 (0.76–3.84) | 0.182 |
| RFS | ||
| TNM Stage III, IV | 2.64 (0.73–9.62) | 0.14 |
| Lymph node metastasis | 0.73 (0.17–3.21) | 0.676 |
| CEA > 5, μg/L | 1.18 (0.56–2.47) | 0.669 |
| AZGP1 | 0.46 (0.21–0.96) | 0.04 |
| Diabetes | 1.28 (0.55–2.97) | 0.561 |
| CA19-9 > 37, U/mL | 1.91 (0.94–3.87) | 0.074 |
| Tumor differentiation | 1.58 (0.81–3.05) | 0.177 |
Bold values indicates statistically significant p values less than 0.05.